NEWS2 versus shock status to stratify antibiotic urgency in patients with suspected sepsis: a retrospective, multicentre cohort study
The Lancet Respiratory Medicine · Published 2026-08-01 · DOI 10.1016/s2213-2600(26)00187-6
Authors (12)
Chanu Rhee, Mervyn Singer, Theodore R Pak, Caroline S McKenna, Anna Agan, Laura DelloStritto, Claire N Shappell, Michael R Filbin, Sayon Dutta, Sameer S Kadri, Edward J Septimus, Michael Klompas
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Rhee, C., Singer, M., Pak, T., et al. (2026). NEWS2 versus shock status to stratify antibiotic urgency in patients with suspected sepsis: a retrospective, multicentre cohort study. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(26)00187-6
Related articles
- Procalcitonin testing combined with NEWS2 evaluation compared with usual care based on NEWS2 for identification of sepsis and antibiotic initiation in the emergency department in England and Wales (PRONTO): a multicentre, randomised, controlled, open-label, phase 3 trial · The Lancet Respiratory Medicine · 2026 · Cites or is cited by this article · Same journal
- Toxic skies of war · The Lancet Respiratory Medicine · 2026 · Same journal
- Cryobiopsy versus conventional bronchoscopic sampling for peripheral pulmonary lesions (Cryo-RCT): an open-label, parallel-group, randomised trial · The Lancet Respiratory Medicine · 2026 · Same journal
- Challenging dogmata of oxygen therapy in acute childhood illness · The Lancet Respiratory Medicine · 2026 · Same journal
- The PERC-Peds rule: a promising step towards structured pulmonary embolism risk assessment in children · The Lancet Respiratory Medicine · 2026 · Same journal
- Sphaerosymphony: turning air quality data into music · The Lancet Respiratory Medicine · 2026 · Same journal
- Effects of inflammatory phenotypes in acute respiratory distress syndrome on mortality and partitioning of lung and chest wall mechanics in patients in the USA and Canada: a retrospective cohort study · The Lancet Respiratory Medicine · 2026 · Same journal
- Global economic burden attributable to asthma, 2025–50: a global modelling analysis of 154 countries and territories · The Lancet Respiratory Medicine · 2026 · Same journal
- Videolaryngoscopy in tactical environments: a word of caution · The Lancet Respiratory Medicine · 2026 · Same journal
- Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort study · The Lancet Respiratory Medicine · 2026 · Same journal